Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 56,109 | 54,160 | 61,415 | 75,082 | 0 |
| Cost of Goods | 3,625 | 1,932 | 2,595 | 4,136 | -104 |
| Gross Profit | 52,484 | 52,228 | 58,820 | 70,946 | 104 |
| Operating Expenses | 64,571 | 56,856 | 51,181 | 47,661 | 1,360 |
| Operating Income | -12,087 | -4,628 | 7,639 | 23,285 | -1,256 |
| Interest Expense | 6,307 | 7,699 | 17,110 | 23,355 | N/A |
| Other Income | 2,095 | -8,136 | -19,332 | -1,075 | 217 |
| Pre-tax Income | -16,299 | -20,463 | -28,803 | -1,145 | -1,039 |
| Income Tax | -968 | -911 | -3,997 | 4,952 | -164 |
| Net Income Continuous | -15,331 | -19,552 | -24,806 | -6,097 | -875 |
| Net Income | $-15,331 | $-19,552 | $-24,806 | $-6,097 | $-875 |
| EPS Basic Total Ops | -0.48 | -0.67 | -0.92 | -0.24 | -0.07 |
| EPS Basic Continuous Ops | -0.48 | -0.67 | -0.92 | -0.24 | -0.07 |
| EPS Diluted Total Ops | -0.48 | -0.67 | -0.92 | -0.24 | -0.07 |
| EPS Diluted Continuous Ops | -0.48 | -0.67 | -0.92 | -0.24 | -0.07 |
| EBITDA(a) | $23,194 | $19,746 | $20,702 | $54,443 | $-1,256 |